Virtus Fund Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Virtus Fund Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.03M	Buy	+67,813	New	+$1.01M	0.01%	281
2017 Q2	–	Sell	-23,425	Closed	-$328K	–	546
2017 Q1	$328K	Sell	23,425 -15,535	-40%	-$221K	﹤0.01%	372
2016 Q4	$621K	Sell	38,960 -7,233	-16%	-$116K	0.01%	306
2016 Q3	$769K	Hold	46,193	–	–	0.01%	294
2016 Q2	$528K	Hold	46,193	–	–	﹤0.01%	331
2016 Q1	$386K	Sell	46,193 -10,084	-18%	-$82.8K	﹤0.01%	366
2015 Q4	$524K	Sell	56,277 -591	-1%	-$5.9K	﹤0.01%	349
2015 Q3	$641K	Buy	+56,868	New	+$696K	0.01%	328
2014 Q3	–	Sell	-2,890	Closed	-$47K	–	1929
2014 Q2	$47K	Buy	+2,890	New	+$38.5K	﹤0.01%	1914

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus Fund Advisers's VNDA Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Vanda Pharmaceuticals (VNDA) in Q4 2017: 67,813 shares worth $1.03M. The stake represents 0.01% of the portfolio and ranks #281 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in VNDA as recently as Q1 2017.

Virtus Fund Advisers first reported a position in VNDA in Q2 2014 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold VNDA as of Q4 2017.

Virtus Fund Advisers held 67,813 shares of Vanda Pharmaceuticals worth $1.03M as of Q4 2017.
Vanda Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
Vanda Pharmaceuticals made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #281 holding.
Virtus Fund Advisers first reported a position in Vanda Pharmaceuticals in Q2 2014 and has held it in 9 quarters since.
125 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.